Please enable JS

Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line

Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line

Publication ID: 
GBI0915002
Publication Date: 
September 01, 2015
Pages: 
113
Publisher: 
GBI Research
Region: 
$4,995.00
Please choose the suitable license type from above. More details are at given under tab "Report License Types" below.
Custom Market Research Reports
Need Custom Market Research Solution?

Want to commission a custom market research to suit your needs? We are here to help. Let us know.